Jung Ho Han

7PUBLICATIONS
11CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Chiropractic
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 19, 2026
Teriflunomide modulates the PD-1/PD-L1 axis and enhances antitumor immunity in colorectal cancer.

Jung Ho Han, Eun-Ji Lee, Young-Hoon Park

|Jan 08, 2025
Caryophylli Cortex Suppress PD-L1 Expression in Cancer Cells and Potentiates Anti-Tumor Immunity in a Humanized PD-1/PD-L1 Knock-In MC-38 Colon Cancer Mouse Model.

Aeyung Kim, Eun-Ji Lee, Jung Ho Han

|Jan 23, 2024
Natural Product-Based Glycolysis Inhibitors as a Therapeutic Strategy for Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer.

Wonyoung Park, Jung Ho Han, Shibo Wei

|Dec 23, 2023
Cosmosiin Induces Apoptosis in Colorectal Cancer by Inhibiting PD-L1 Expression and Inducing ROS.

Jung Ho Han, Eun-Ji Lee, Wonyoung Park

|Sep 28, 2023
Single-Cell RNA Sequencing Reveals Immuno-Oncology Characteristics of Tumor-Infiltrating T Lymphocytes in Photodynamic Therapy-Treated Colorectal Cancer Mouse Model.

Eun-Ji Lee, Jang-Gi Choi, Jung Ho Han

|Jun 02, 2021
Targeting Lactate Dehydrogenase A with Catechin Resensitizes SNU620/5FU Gastric Cancer Cells to 5-Fluorouracil.

Jung Ho Han, MinJeong Kim, Hyeon Jin Kim

Pageof 2

Frequent Collaborators

5 joint publications

Hwan-Suck Chung

4 joint publications

Ki-Tae Ha

3 joint publications

Sung-Jin Bae

3 joint publications

Dongryeol Ryu